- Home
- EVG vs ALEC Comparison
EVG vs ALEC Comparison
Compare EVG & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVG
- ALEC
- Stock Information
- Founded
- EVG 2005
- ALEC 2013
- Country
- EVG United States
- ALEC United States
- Employees
- EVG N/A
- ALEC N/A
- Industry
- EVG Investment Managers
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVG Finance
- ALEC Health Care
- Exchange
- EVG Nasdaq
- ALEC Nasdaq
- Market Cap
- EVG 146.4M
- ALEC 124.0M
- IPO Year
- EVG N/A
- ALEC 2019
- Fundamental
- Price
- EVG $10.79
- ALEC $1.33
- Analyst Decision
- EVG
- ALEC Buy
- Analyst Count
- EVG 0
- ALEC 7
- Target Price
- EVG N/A
- ALEC $4.70
- AVG Volume (30 Days)
- EVG 49.4K
- ALEC 1.2M
- Earning Date
- EVG 01-01-0001
- ALEC 05-08-2025
- Dividend Yield
- EVG 8.68%
- ALEC N/A
- EPS Growth
- EVG N/A
- ALEC N/A
- EPS
- EVG N/A
- ALEC N/A
- Revenue
- EVG N/A
- ALEC $88,339,000.00
- Revenue This Year
- EVG N/A
- ALEC N/A
- Revenue Next Year
- EVG N/A
- ALEC $392.45
- P/E Ratio
- EVG N/A
- ALEC N/A
- Revenue Growth
- EVG N/A
- ALEC N/A
- 52 Week Low
- EVG $9.13
- ALEC $0.87
- 52 Week High
- EVG $10.86
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- EVG 49.46
- ALEC 55.51
- Support Level
- EVG $10.71
- ALEC $1.01
- Resistance Level
- EVG $10.90
- ALEC $1.46
- Average True Range (ATR)
- EVG 0.12
- ALEC 0.12
- MACD
- EVG -0.01
- ALEC 0.02
- Stochastic Oscillator
- EVG 38.24
- ALEC 71.11
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.